BPC-157 (Body Protection Compound)
Mechanism: Gastric pentadecapeptide that heals the gut lining, upregulates the body's antioxidant system, and promotes systemic tissue repair. Works through nitric oxide pathways and growth factor modulation. Described as capable of "turning off inflammation at a genetic level" in clinical settings.
Dosing Protocol:
- Standard dose: 250-500 mcg/day via subcutaneous injection
- Oral BPC-157: Superior to injectable specifically for gut healing — delivers peptide directly to the gut lining
- Cycle: 4-6 weeks on, 2 weeks off
- Injection site: Systemic biodistribution confirmed — injection does not need to occur at the injury site, though local injection may enhance local effects
Evidence Tier: Expert Opinion (multiple clinical practitioners), with supporting animal studies
Stacking:
- BPC-157 + TB-500 ("The Wolverine Stack"): Recommended combination for nagging injuries, slow recovery, and gut issues. Standard protocol: 500 mcg of each daily. BPC-157 handles tissue repair while TB-500 promotes angiogenesis and cellular migration — complementary mechanisms
- BPC-157 + KPV + Larazotide: Clinical stack for gut and systemic inflammation. Each peptide addresses distinct mechanisms — BPC-157 for lining repair, KPV for immune modulation, Larazotide for tight junction integrity
Safety Notes:
- Generally well-tolerated in clinical settings
- Must source from 503A compounding pharmacy — research-grade peptides are NOT equivalent to pharmaceutical-grade
- Potential interaction with blood thinners (theoretical, limited data)
- Used under medical supervision in functional medicine programs
Sources: Jay Campbell YouTube (5 findings), DrJonesDC YouTube (3 findings), r/Peptides, PubMed animal studies
TB-500 (Thymosin Beta-4)
Mechanism: Promotes new blood vessel growth (angiogenesis) and improves cellular migration to damaged areas. These mechanisms are complementary to BPC-157's tissue repair effects, which is why they are frequently stacked.
Dosing Protocol:
- Standard dose: 500 mcg/day subcutaneous injection
- High-dose protocol (serious injuries): Up to 2,000 mcg/day — used clinically for significant injuries
- Cycle: 4-6 weeks, with dose escalation as needed
- Administration: Systemic — injection site independence confirmed; subcutaneous in abdomen or near injury site
Evidence Tier: Expert Opinion (clinical practitioners), supported by animal studies
Stacking:
- Primary stack: BPC-157 + TB-500 at 500 mcg each daily ("Wolverine Stack")
- Escalated stack: For serious injuries, TB-500 can be increased to 2,000 mcg while BPC-157 remains at 500 mcg
- Synergy: BPC-157 focuses on tissue repair and gut healing; TB-500 focuses on blood vessel formation and cell migration. Together they address both the structural and vascular components of recovery
Safety Notes:
- Well-tolerated at standard doses
- High-dose protocols should be monitored by a practitioner
- Source from 503A compounding pharmacy only
Sources: Jay Campbell YouTube (4 findings), clinical practitioner reports, r/Peptides community
GHK-Cu (Copper Peptide)
Mechanism: Tripeptide with copper binding that promotes wound healing, collagen synthesis, and tissue remodeling. Acts as a signaling molecule that recruits repair processes. Also demonstrates anti-inflammatory and antioxidant properties.
Dosing Protocol:
- Topical: 2% concentration cream/serum for localized skin and wound healing
- Injectable (SubQ): 1-2 mg/day for systemic effects
- Cycle: Can be used continuously for topical; 4-6 week cycles for injectable
- Route comparison: Topical is preferred for skin/wound healing; injectable for systemic anti-inflammatory and deeper tissue effects
Evidence Tier: Animal studies with emerging human observational data
Stacking:
- Complementary with BPC-157: GHK-Cu handles extracellular matrix remodeling while BPC-157 addresses tissue-level repair
- Recovery triad: BPC-157 + TB-500 + GHK-Cu covers tissue repair (BPC-157), vascularization (TB-500), and matrix remodeling (GHK-Cu)
Safety Notes:
- Topical application is very well-tolerated
- Injectable use should be pharmaceutical-grade
- Copper accumulation is theoretical at standard doses but worth monitoring in extended use
Sources: Jay Campbell podcast, PubMed (wound healing studies), r/Peptides
Recommended Protocol Summary
For a 40-year-old active male focused on training recovery:
| Peptide | Dose | Route | Frequency | Duration | |---------|------|-------|-----------|----------| | BPC-157 | 500 mcg | SubQ (abdomen) | Daily | 4-6 weeks | | TB-500 | 500 mcg | SubQ (abdomen) | Daily | 4-6 weeks | | GHK-Cu | 2% topical | Skin application | Daily | Ongoing |
Cycling: Run BPC-157 + TB-500 for 4-6 weeks, take 2 weeks off, repeat as needed. GHK-Cu topical can continue through off-cycles.
Escalation (for acute injuries): Increase TB-500 to 1,000-2,000 mcg/day for 1-2 weeks, then return to maintenance dose.
Sourcing: All peptides must be obtained from a 503A compounding pharmacy. Research-grade peptides are not suitable for human use.
All recommendations are based on publicly available research and clinical practitioner reports. This is not medical advice. Consult a qualified healthcare provider before starting any peptide protocol.